Kappen L S, Suzuki H, Goldberg I H
Proc Natl Acad Sci U S A. 1973 Jan;70(1):22-6. doi: 10.1073/pnas.70.1.22.
Pactamycin does not inhibit the overall initiation factor- and GTP-dependent binding of [(35)S]Met-tRNA(f) to rabbit reticulocyte ribosomes but does prevent the formation of Met-puromycin, provided that the antibiotic is present during the course of the binding reaction. These data indicate that pactamycin blocks the synthesis of a functional peptide-chain initiation complex. Sucrose density gradient centrifugation analysis of binding reactions shows that pactamycin causes the accumulation of an initiation complex on the smaller ribosomal subunit (smaller initiation complex), to which the 60S ribosomal subunit either cannot join or with which it forms a larger inactive 80S initiation complex that falls apart under the conditions used for isolation. The smaller initiation complex formed in the presence of pactamycin differs from the normal intermediate in peptide-chain initiation in being much more resistant to degradation by pancreatic RNase. In the presence of pactamycin, the inactive smaller complex can also form on mRNA to which an unaffected ribosomal couple is already attached, forming an oligoribosome lacking a larger ribosomal subunit or a "1.5 mer." These effects of pactamycin can be overcome to a considerable degree by elevation of the Mg(2+) concentration.
pactamycin并不抑制[(35)S]甲硫氨酰 - tRNA(f)与兔网织红细胞核糖体的整体起始因子及GTP依赖性结合,但如果在结合反应过程中存在该抗生素,则会阻止甲硫氨酰 - 嘌呤霉素的形成。这些数据表明pactamycin阻断了功能性肽链起始复合物的合成。结合反应的蔗糖密度梯度离心分析表明,pactamycin导致起始复合物在较小的核糖体亚基上积累(较小的起始复合物),60S核糖体亚基要么无法与之结合,要么与之形成更大的无活性80S起始复合物,该复合物在用于分离的条件下会解体。在pactamycin存在下形成的较小起始复合物与肽链起始过程中的正常中间体不同,它对胰核糖核酸酶的降解具有更强的抗性。在pactamycin存在下,无活性的较小复合物也可在已附着有未受影响的核糖体对的mRNA上形成,形成缺乏较大核糖体亚基的寡核糖体或“1.5聚体”。通过提高Mg(2+)浓度,pactamycin的这些作用在很大程度上可以被克服。